Amin Dipti bought LCTX
July 1, 2026 · Form 4 insider transaction
Amin Dipti bought 125,000 shares of Lineage Cell Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderAmin Dipti
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after125,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Will vest and become exercisable on the earlier of July 1, 2027 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer.